Demographic characteristics
| | | |
Age (years) | 54 (16) | 54 (16) | 54 (16) |
Body mass index (kg/m2) | 26 (6) | 26 (5) | 26 (6) |
Female, No (%) | 225 (80) | 110 (81) | 115 (79) |
Postmenopausal women, No (% of the women) | 138 (61) | 63 (57) | 75 (65) |
| | | |
Disease related characteristics
| | | |
Duration of RA (years) | 6 (9) | 5 (7) | 7 (11)* |
Rheumatoid factor positive, No (%) | 197 (70) | 96 (71) | 101 (70) |
DMARDs used in the past (n) | 2 (1–2) | 1 (1–2) | 2 (1−2) |
Current use of DMARDs, No (%) | 241 (86) | 111 (82) | 130 (90) |
Current use of glucocorticoids, No (%) | 25 (8.9) | 11 (8.1) | 14 (9.7) |
ESR (mm/1st h) | 16 (21) | 16 (21) | 16 (22) |
44 Joint count for swelling (0–44) | 12 (12) | 12 (12) | 11 (12) |
Ritchie Articular Index (0–78) | 8.0 (10.0) | 8 (10.0) | 9 (11.0) |
Patient’s global assessment of disease activity (0–100) | 3.2 (4.1) | 3.0 (4.0) | 3.3 (4.3) |
DAS4 (0–10) | 3.3 (0.7) | 3.2 (1.4) | 3.4 (2.0) |
HAQ (0–3) | 0.63 (0.75) | 0.63 (0.88) | 0.63 (0.84) |
Aerobic fitness (W) | 162 (74) | 162 (74) | 162 (74) |
Larsen score (0–200) | 31.0 (58.0) | 24.0 (54.5) | 37.5 (54.5)* |
Bone mineral density (g/cm2) | 0.909 (0.194) | 0.912 (0.210) | 0.906 (0.187) |